Dear Steve and Elissa, I am writing on behalf of the Niemann-Pick Type C (NPC) Therapy Accelerator in regard to the adrabetadex program.  Specifically, we would like to set up a time to speak with Mallinckrodt (MNK) about the future of adrabetadex, and discuss possibilities for allowing the NPC community to gain access to the investigational product and the related … Read More